Trial Condition(s):
Contraception
Data on Oral Contraceptives Compliance in Non Stop Regimen (DOC Non Stop)
Bayer Identifier:
15253
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Adherence to the dosing scheme is the principal element of COC efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.
Inclusion Criteria
- Patients at the age of 18-50 requiring contraception, treated with oral contraceptives designed for the scheme 28 pills for 28 days. The decisions would be made at the discretion of the attending physician.
Exclusion Criteria
- Patients were not valid for analysis if the initial visit was before start of study in the country (retrospective documentation), or if they did not take oral contraceptives designed for the scheme 28 pills for 28 days.
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Many Locations, Poland | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Observation of compliance with dosage in women using oral contraceptives designed for the non stop use, (it means 28 pills for 28-days cycle).
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- The percentage of users showing noncompliant behaviorsTimeframe: 3 consecutive cycles (28-days per cycle)
Secondary Outcome
- The characteristics of noncompliant behavior.Timeframe: 3 consecutive cycles (28-days per cycle)
- The relation between noncompliant behavior and selected factors.Timeframe: 3 consecutive cycles (28-days per cycle)
Additional Information
Copyright © Bayer
Powered by
